U.S. Tech Hardware Stock News

Portnoy Law Firm has launched a securities fraud investigation into Cleveland-Cliffs (NYSE:CLF) following the company’s recent financial disclosure. Cleveland-Cliffs reported a revenue decline and larger than expected losses, alongside plans to idle six steel plants and exit loss-making business segments. The investigation is being framed as a potential class action on behalf of investors who experienced stock value losses. Cleveland-Cliffs, trading at about $8.46, has seen sharp share...

Why Markel Group’s Recent Share Slide Has Caught Investor Attention Markel Group (MKL) has seen its share price move lower recently, with a 7% decline over the past month and a 10% decline over the past 3 months, prompting closer scrutiny from investors. See our latest analysis for Markel Group. The recent 1 month share price return of negative 7.45% and 3 month share price return of negative 10.39% suggest fading short term momentum. However, the 1 year total shareholder return of 5.13% and...

Travel + Leisure (TNL) is in focus after its board approved a 7% increase in the regular quarterly cash dividend to $0.60 per share, payable on March 31, 2026. See our latest analysis for Travel + Leisure. The higher dividend comes after a strong run for investors, with a 1 year total shareholder return of 48.61% and a 3 year total shareholder return of 105.64%. However, the recent 7 day share price return of 6.32% and 30 day share price return of 5.21% show momentum has cooled at a latest...

Guardant Health (GH) has put its colorectal cancer blood test Shield in the spotlight after launching Shield Across America, a nationwide mobile screening tour aimed at expanding access in underserved communities during National CRC Awareness Month. See our latest analysis for Guardant Health. Against this backdrop, Guardant Health’s 1-day share price return of 1.75% to US$85.49 comes after a 30-day share price return decline of 20.53% and a year-to-date share price return decline of 15.97%,...

JOYY Inc. has reported its fourth-quarter and full-year 2025 results, returned to profitability, and reinforced shareholder payouts with a quarterly dividend program through 2027, an additional special dividend, and completion of a US$159.7 million share repurchase covering 5.54% of its shares. The combination of accelerating BIGO Ads growth, improving social entertainment operations, and sizable capital returns highlights how JOYY is reshaping its revenue mix while actively using its...

Century Communities' multifamily division, Century Living, has acquired a shovel-ready site in Denver's LoHi neighborhood for a luxury apartment project called The Stevie. Groundbreaking is set to begin imminently, with leasing currently projected to start in 2028. The Stevie represents an expansion for NYSE:CCS further into high-end multifamily development in a central Denver location. Century Communities, listed on the NYSE under ticker CCS, is primarily known for building single-family...

Why Coursera’s growth push is back in focus Recent commentary on Coursera (COUR) has zeroed in on its choice to prioritize user growth, with average revenue per customer falling 8.1% annually and estimates pointing to slower sales growth ahead. At the same time, Coursera is carrying high marketing expenses to keep attracting learners. This highlights a tension between expanding the platform and improving profitability that many investors are reassessing. See our latest analysis for...

In March 2026, MercadoLibre said it would invest US$3.40 billion in Argentina in 2026, about 30% more than its previously outlined 2025 spending, to expand logistics, add distribution centers, enhance its technology platform, grow Mercado Pago and create nearly 2,000 local jobs. This larger commitment in its home market comes as the company faces rising competition, thinner margins and heightened scrutiny of its profitability strategy across Latin America. Now we’ll explore how this...

Event context and recent performance Hubbell (HUBB) shares have recently eased, with a return of about 9% decline over the past month, while still showing a roughly 4% gain over the past 3 months and a 39% total return over the past year. See our latest analysis for Hubbell. That recent 9% 1 month share price pullback contrasts with a modest 3 month share price return and a much stronger 1 year total shareholder return of 38.8%, hinting that momentum has cooled after a solid multi year...

If you are wondering whether Crinetics Pharmaceuticals at around US$37.49 is a bargain or already pricing in a lot of optimism, you are asking the right question for a valuation check. The stock has seen a 21.3% decline over the last 30 days and is down 19.8% year to date, even though its 1 year return is 8.8% and its 3 year return is 117.3%. Recent attention on Crinetics has focused on its progress as a pharmaceuticals and biotech company, including ongoing development work that shapes...

Dividend, Buyback Expansion and Downgrade Put Badger Meter in Focus Badger Meter (BMI) is back on investors’ radar after the company declared a regular quarterly dividend and raised its share repurchase authorization by $75 million, while Argus Research cut its rating from Buy to Hold. See our latest analysis for Badger Meter. At a share price of $146.59, Badger Meter has seen a 1.59% 1 day share price return. Its 30 day share price return of 6.58% and year to date share price return of...

Babcock & Wilcox Enterprises recently reported fourth-quarter 2025 results showing flat sales at US$161.0 million but a swing to US$9.2 million in net income, alongside news of a US$2.40 billion design-build agreement to deliver 1.2 GW of natural gas-fired power capacity for AI-focused data centers. Together with an amended credit facility extending debt maturity to 2028 and an ongoing preferred dividend, these developments highlight how AI-driven power projects and financing flexibility are...

Oracle is expanding its Health Clinical AI Agent for medical note generation across U.S. emergency departments and inpatient settings. The rollout is reaching more major healthcare providers, with reported reductions in documentation time and smoother clinician workflows. This move highlights a practical use of Oracle's AI capabilities in a highly regulated, mission critical part of the healthcare system. For investors watching NYSE:ORCL, this update sits alongside a share price of $155.11...

China has approved Pfizer's GLP-1 obesity therapy Xianweiying (ecnoglutide), granting the company commercialization rights in mainland China. The therapy was obtained from Sciwind Biosciences and targets the fast growing weight management drug market. This move adds a new obesity treatment to Pfizer's portfolio alongside its existing non COVID growth efforts. For NYSE:PFE holders watching how the business evolves beyond its COVID franchise, this approval puts a fresh spotlight on obesity...

If you are trying to figure out whether NewMarket's current share price fairly reflects its fundamentals, you are in the right place. The stock recently closed at US$584.66, after a 7 day return of an 8.8% decline, a 30 day return of a 16.2% decline, and a year to date return of a 15.0% decline, set against a 1 year return of 13.2%, a 3 year return of 78.2%, and a 5 year return of 66.4%. Recent coverage has focused on how NewMarket's share price performance over multiple time frames may...

If you are wondering whether Tyler Technologies is starting to look interesting at its current share price, this article will walk through what the numbers are saying about value. The stock closed at US$349.79 most recently, after a 6.6% decline over the last 7 days, a 3.1% gain over 30 days, and returns of 19.7% decline year to date and 37.9% decline over the past year. The 3 year and 5 year returns sit at 7.1% and 16.7% decline respectively. Recent coverage has continued to focus on Tyler...

If you are wondering whether Airbnb's share price still lines up with what the business is worth, this article will walk through how the numbers stack up and where the valuation questions really sit. Airbnb's stock last closed at US$126.30, with returns of 5.6% over the past 30 days, a 5.0% decline year to date, a 2.8% gain over 1 year, a 6.9% gain over 3 years and a 35.0% decline over 5 years. Taken together, these figures give a mixed picture of how the market has been updating its...

CleanSpark, Inc. recently reported unaudited February 2026 operating results, producing 568 Bitcoin with an average daily output of 20.29 and a peak single-day production of 23.84. At the same time, the company’s shift toward high-performance computing and AI-focused data centers is drawing attention to how its large contracted power capacity might support a broader, more flexible computing business beyond Bitcoin mining. With this backdrop, we’ll examine how CleanSpark’s move into AI and...

Recent performance snapshot Zions Bancorporation National Association (ZION) has recently drawn attention after a period of weak share performance, with the stock showing a 2.1% decline in the latest session and negative returns over the past week and month. In this context, investors are considering how the bank's current share price compares with its recent financial profile, including reported revenue of US$3,313.0m, net income of US$884.0m, and a value score of 6. See our latest analysis...

On March 5, 2026, Wingstop’s board increased its share repurchase authorization by US$300 million, bringing the total buyback capacity to about US$1.05 billion, funded by existing cash and anticipated operating cash flow. This larger buyback plan, coming after nearly US$700 million already spent to repurchase roughly 2.6 million shares since 2023, underscores management’s preference for returning excess capital to shareholders even as same-store sales have recently softened. Next, we’ll...

If you are looking at Blackbaud and wondering whether the current share price reflects its true worth, you are not alone. This article is built to help you weigh what you are paying against what you are getting. The stock most recently closed at US$44.03, with returns of an 8.6% decline over the last 7 days, a 12.6% decline over the last 30 days, a 26.0% decline year to date and a 30.6% decline over the past year, alongside a 22.9% decline over three years and a 37.9% decline over five...

Earlier this week, Qorvo reported an exceptional quarter with revenue up 8.4% year on year, beating analyst expectations for earnings per share and adjusted operating income, as all operating segments grew, led by automotive components, consumer and enterprise Wi‑Fi, base stations, and power management. Management also flagged an expected seasonal dip tied to its largest customer and the ongoing resizing of its Android business, while emphasizing continued strength in its High Performance...

Carvana’s first stock split puts affordability and access in focus Carvana (CVNA) is drawing fresh investor attention after its Board of Directors approved the company’s first ever 5-for-1 stock split, pending a shareholder vote at the upcoming annual meeting. See our latest analysis for Carvana. At a share price of US$300.15, Carvana has seen a 1 year total shareholder return of 65.66% and a very large 3 year total shareholder return, even as the 30 day share price return of 17.56% and year...

Recent performance context for Pinnacle Financial Partners (PNFP) Pinnacle Financial Partners (PNFP) has seen its share price under pressure lately, with a 0.8% decline in the latest session and negative moves over the past week, month and past 3 months. See our latest analysis for Pinnacle Financial Partners. At the current share price of $82.89, recent weakness in the 1 month and year to date share price returns contrasts with a much stronger 3 year total shareholder return. This...